BASSI, ROSARIA
BASSI, ROSARIA
Dipartimento di Biotecnologie Mediche e Medicina Traslazionale
Ceramide Is Involved in Temozolomide Resistance in Human Glioblastoma U87MG Overexpressing EGFR
2023 R. Bassi, M. Dei Cas, C. Tringali, F. Compostella, R. Paroni, P. Giussani
Cross‐talk between CFTR and sphingolipids in cystic fibrosis
2023 D. Dobi, N. Loberto, R. Bassi, A.S. Pistocchi, G. Lunghi, A. Tamanini, M. Aureli
Massive Accumulation of Sphingomyelin Affects the Lysosomal and Mitochondria Compartments and Promotes Apoptosis in Niemann-Pick Disease Type A
2022 E.V. Carsana, G. Lunghi, S. Prioni, L. Mauri, N. Loberto, A. Prinetti, F.A. Zucca, R. Bassi, S. Sonnino, E. Chiricozzi, S. Duga, L. Straniero, R. Asselta, G. Soldà, M. Samarani, M. Aureli
Hybrid lipid/polymer nanoparticles to tackle the cystic fibrosis mucus barrier in siRNA delivery to the lungs : does PEGylation make the difference?
2022 G. Conte, G. Costabile, D. Baldassi, V. Rondelli, R. Bassi, D. Colombo, G. Linardos, E.V. Fiscarelli, R. Sorrentino, A. Miro, F. Quaglia, P. Brocca, I. D'Angelo, O.M. Merkel, F. Ungaro
β-Glucocerebrosidase Deficiency Activates an Aberrant Lysosome-Plasma Membrane Axis Responsible for the Onset of Neurodegeneration
2022 G. Lunghi, E.V. Carsana, N. Loberto, L. Cioccarelli, S. Prioni, L. Mauri, R. Bassi, S. Duga, L. Straniero, R. Asselta, G. Soldà, A. Di Fonzo, E. Frattini, M. Magni, N. Liessi, A. Armirotti, E. Ferrari, M. Samarani, M. Aureli
Evaluation of phages and liposomes as combination therapy to counteract Pseudomonas aeruginosa infection in wild-type and CFTR-null models
2022 M. Cafora, N. Poerio, F. Forti, N. Loberto, D. Pin, R. Bassi, M. Aureli, F. Briani, A. Pistocchi, M. Fraziano
Extracellular Sphingosine-1-Phosphate Downstream of EGFR Increases Human Glioblastoma Cell Survival
2021 R. Bassi, S. Brambilla, C. Tringali, P. Giussani
Hyaluronic acid-dexamethasone nanoparticles for local adjunct therapy of lung inflammation
2021 C.I. Camara, L. Bertocchi, C. Ricci, R. Bassi, A. Bianchera, L. Cantu', R. Bettini, E. Del Favero
GM1 as adjuvant of innovative therapies for cystic fibrosis disease
2020 G. Mancini, N. Loberto, D. Olioso, M.C. Dechecchi, G. Cabrini, L. Mauri, R. Bassi, D. Schiumarini, E. Chiricozzi, G. Lippi, E. Pesce, S. Sonnino, N. Pedemonte, A. Tamanini, M. Aureli
Sphingolipids and plasma membrane hydrolases in human primary bronchial cells during differentiation and their altered patterns in cystic fibrosis
2020 N. Loberto, G. Mancini, R. Bassi, E.V. Carsana, A. Tamanini, N. Pedemonte, M. Cristina Dechecchi, S. Sonnino, M. Aureli
Exploring the effect of chirality on the therapeutic potential of N-alkyl-deoxyiminosugars: anti-inflammatory response to Pseudomonas aeruginosa infections for application in CF lung disease
2019 M. De Fenza, D. D'Alonzo, A. Esposito, S. Munari, N. Loberto, A. Santangelo, I. Lampronti, A. Tamanini, A. Rossi, S. Ranucci, I. De Fino, A. Bragonzi, M. Aureli, R. Bassi, M. Tironi, G. Lippi, R. Gambari, G. Cabrini, G. Palumbo, M.C. Dechecchi, A. Guaragna
Sphingolipids role in the regulation of inflammatory response: From leukocyte biology to bacterial infection
2018 E. Chiricozzi, N. Loberto, D. Schiumarini, M. Samarani, G. Mancini, A. Tamanini, G. Lippi, M.C. Dechecchi, R. Bassi, P. Giussani, M. Aureli
Abiraterone and ionizing radiation alter the sphingolipid homeostasis in prostate cancer cells
2018 V. Murdica, G. Mancini, N. Loberto, R. Bassi, P. Giussani, N. Di Muzio, C. Deantoni, A. Prinetti, M. Aureli, S. Sonnino
A lysosome-plasma membrane-sphingolipid axis linking lysosomal storage to cell growth arrest
2018 M. Samarani, N. Loberto, G. Soldà, L. Straniero, R. Asselta, S. Duga, G. Lunghi, F.A. Zucca, L. Mauri, M.G. Ciampa, D. Schiumarini, R. Bassi, P. Giussani, E. Chiricozzi, A. Prinetti, M. Aureli, S. Sonnino
Crosstalk between sphingosine-1-phosphate and EGFR signalling pathways enhances human glioblastoma cell invasiveness
2018 M.G. Cattaneo, C. Vanetti, M. Samarani, M. Aureli, R. Bassi, S. Sonnino, P. Giussani
Crosstalk between S1P and EGFR signalling pathways in human glioma cell invasiveness
2017 M. Cattaneo, C. Vanetti, M. Samarani, M. Aureli, R. Bassi, S. Sonnino, P. Giussani
Sphingosine-1-P and its plasma membrane receptors in human glioma cells
2017 M. Cattaneo, C. Vanetti, M. Samarani, M. Aureli, R. Bassi, S. Sonnino, P. Giussani
Evidence for the involvement of lipid rafts and plasma membrane sphingolipid hydrolases in pseudomonas aeruginosa infection of cystic fibrosis bronchial epithelial cells
2017 D. Schiumarini, N. Loberto, G. Mancini, R. Bassi, P. Giussani, E. Chiricozzi, M. Samarani, S. Munari, A. Tamanini, G. Cabrini, G. Lippi, M.C. Dechecchi, S. Sonnino, M. Aureli
Bladder cancer cell growth and motility implicate cannabinoid 2 receptor-mediated modifications of sphingolipids metabolism
2017 A. Bettiga, M. Aureli, G. Colciago, V. Murdica, M. Moschini, R. Lucianò, D. Canals, Y. Hannun, P. Hedlund, G. Lavorgna, R. Colombo, R. Bassi, M. Samarani, F. Montorsi, A. Salonia, F. Benigni
Neoglycoconjugates Derived from Deoxynojirimycin as Possible Therapeutic Agents for Cystic Fibrosis Lung Disease, by Modulation of the Sphingolipid Metabolism
2016 S. Munari, N. Loberto, M. Aureli, B. Vauzeilles, A. Baron, N. Guisot, D. Schiumarini, R. Bassi, M. Tironi, M.G. Giri, A. Tamanini, G. Lippi, G. Cabrini, S. Sonnino, M.C. Dechecchi